Abstract
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have